Clostridium perfringens septicaemia
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female
Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma
Second autologous transplant as salvage therapy in multiple myeloma
Guideline: the laboratory diagnosis of malaria
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study
Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia
Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma
Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling
A common novel splice variant of SLC22A1 ( OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia
Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study
Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis
Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up
A prenatal origin of childhood essential thrombocythaemia
Normal prion protein is expressed on exosomes isolated from human plasma
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma
Correlating prothrombin time with plasma rivaroxaban level
Corrigendum